BRIEF-AstraZeneca CEO says MYSTIC cancer drug trial "not binary"
Feb 2 (Reuters) - Astrazeneca CEO Pascal Soriot told reporters after Q4 results: [Source]
Publication Date:Origin: reuters.com
Category: governmentFilingsNews
Topics: results, told reporters, Soriot, Pascal, Astrazeneca, (Reuters), binary", trial, cancer, MYSTIC, BRIEF-AstraZeneca
Source: http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/PyHV_T_bs7g/idUSL9N15G03S